MICHEL REMY CORBOZ
Green Brook, NJ 08812
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
RESPIRATORY SCIENTIST
Extensive, diverse experience focusing on discovery and development of
respiratory drugs within major pharmaceutical companies. Broad knowledge
and expertise in respiratory pharmacology and physiology and their
implementation into relevant animal models of human disease. Excellent
written and verbal communication skills with 50 publications in peer-
reviewed journals. Additional experience and expertise in cardiovascular
and neurophysiology.
Professional Experience
YOURENCORE, Princeton, NJ 2012
Independent Consultant
. Provide consulting services focusing on discovery and development of
respiratory drug and early development.
. Broad knowledge and expertise in design and conduct of respiratory animal
models.
. Highly regarded and selected for peer reviews.
. Extensive experience in writing scientific papers.
MERCK, Kenilworth, NJ 2009 - 2011
In-Vivo Group
Principal Scientist
. Evaluated new inhaled drugs and formulations in rodents (in vivo).
. Established a guinea pig model for cardiovascular measurement (blood
pressure and heart rate). Assessment of bronchodilatory drugs.
. Established an isolated lung preparation to study intratracheal
deposition and lung retention of drugs.
. Developed the rat model of lipopolysaccharide (LPS)-induced pulmonary
inflammation model (neutrophilic lung inflammation).
. Developed relevant end-points of human asthma and COPD in animals
including biomarker strategies for target engagement.
SCHERING-PLOUGH, Kenilworth, NJ 1997 - 2009
Allergy and Immunology Group
Principal Scientist (2001 - 2009)
. Discovered new oral drugs including targets such as ?2C-adrenoceptor
agonist. Organized, presented and documented scientific data to senior
management and the executive committee.
. Conceived and championed a project since basic research to clinical
recommendation for two indications (respiratory and neuropathic pain).
. Chair of Discovery meeting in area of Respiratory Pharmacology (next
generation of nasal decongestant) and CNS (neuropathic pain).
. Member of Early Development Team in area of Respiratory Pharmacology that
advanced compounds in GLP toxicology testing and Phase I trials.
. In charge of the New Drug Recommendation Document; Active participant in
the writing of the preclinical biology sections of the Investigator New
Drug (IND) and Investigator Brochures (IB).
. Involved in many respiratory programs which led to clinical
recommendation of several compounds.
. Developed techniques using different airway preparations (nasal mucosa,
trachea, bronchi and isolated lung, in vivo) with increasing
physiological complexity.
. Discovered new oral and topical drugs for nasal congestion. Developed
methods to evaluate compound efficacy against key end points of nasal
congestion. Established an in vitro human bioassay for screening.
Developed techniques to assess nasal constrictor/vasodilatory effects of
drugs in rodent, primate and human tissues.
. Developed in vitro method to measure airway gland secretions (Hillock
technique).
MICHEL REMY CORBOZ
Page Two
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
Principal Scientist, (Continued)
. Established isolated lung and tissue preparations with electrical field
stimulation to study neural mechanism in the airways.
. Explored the feasibility of a pulmonary hypertension ex-vivo model for
COPD and a rodent model for rhinosinusitis.
. Established techniques to measure CNS and cardiovascular effects in rats.
Techniques included mydriasis, blood pressure and heart rate measurements
in conscious animals (normal and spontaneously hypertensive rat).
. Developed method to measure hyperventilation-induced bronchoconstriction
(in vivo).
. Published over 25 manuscripts on in vitro and in vivo animal models of
nasal congestion, asthma, COPD and pharmacology, including review
articles (see accompanying attachment).
. Invited speaker to International Symposia on the mechanism of nasal
congestion.
Associate Principal Scientist (1997 - 2000)
. Team member for tachykinin antagonist project and for histamine
antagonist project that discovered potent and selective tachykinin and
histamine antagonists. Preclinical biologist on these two projects.
. Published numerous articles (12) in this area. Received Presidential
Award for Outstanding Scientific Achievement from Schering-Plough for
work in the tachykinin field.
UNIVERSITY OF SOUTH ALABAMA, Mobile, AL 1996 - 1997
Instructor (1996 - 1997)
Research Associate (1996)
. Established an in vivo model for visualization (intravital microscopy) of
tracheal circulation.
. Team member for evaluating airway submucosal glands and mucus secretion.
. Manuscripts (11) were published on mucus secretion and tracheal
circulation.
. Teaching (see accompanying attachment).
Education
. Postdoctorat, Pulmonary Physiology, Department of Physiology, College of
Medicine, Mobile, AL, USA
. PhD (Highest Honors), Pulmonary Physiology, Laboratory of Physiology,
Faculty of Medicine, University J. Fourier of Grenoble, France
. MS, Animal Physiology, Laboratory of Physiology, University J. Fourier
Grenoble, France
. BS, Sciences of Nature and Life, University J. Fourier Grenoble, France
Professional Development and Training
Teaching
. Lectured course on pulmonary physiology, McKinley School, Newark, NJ
(1998-2006)
. Lectured course on pulmonary physiogy to undergraduate and graduate
students, University of South Alabama (1994-1997)
. Lectured laboratory on pulmonary physiogy to medical students, University
of South Alabama (1992-1997)
. Lectured course and lectured laboratory on neurophysiogy and pulmonary
physiogy to college students, University J. Fourier Grenoble, France
(1990-1991)
Student training
. Summer Intern Program (200*-****-****)
. Post-Doctoral Student (2000-2001)
MICHEL REMY CORBOZ
Page Three
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
Manuscript review for numerous journals
. American Journal of Physiology
. Anatomical Record
. British Journal of Pharmacology
. Critical Care Medicine
. Experimental Lung Research
. Journal of Pharmacology and Experimental Therapeutics
. Microvascular Research
. Naunyn-Schmiedeberg 's Archives of Pharmacology
. Respiratory Research
Invited Speaker
. Pulmonary Research Group - Spring 2006 Symposium, Upper Airway Disease:
Clinical and Research Perspectives, May 4th 2006, Allergy and Asthma
Center, John Hopkins, Baltimore, MD, USA
. IX International Da Vinci Society Meeting on Airway Circulation, Pulm.
Pharmacol. & Therap. September 23-25th 2005, Camogli, Italy
. VIII International Da Vinci Society Meeting on Airway Circulation, Pulm.
Pharmacol. & Therap. September 25-27th 2003, Nimes, France
. University of South Alabama, Nasal Mucosa, January 21th 2002, Mobile, AL,
USA
AFFILIATIONS
American Physiological Society
American Thoracic Society
Da Vinci Society
Microcirculatory Society
New Jersey Thoracic Society
Pulmonary Research Group
ACHIEVEMENTS and Awards
Presidential Award for Outstanding Group Achievement (1998)
MICHEL REMY CORBOZ
Page Four
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
Articles and Monographs
1. CORBOZ M.R, M.A. RIVELLI, C. CORELL, R. CHAPMAN
Role of nitric oxide and arginase on muscarinic-induced contractility in
allergen-challenged Brown Norway rat trachea. In Preparation.
2. CORBOZ M.R, J. PALAMANDA, M.A. RIVELLI, C. MORGAN, G.B. VARTY, C.W.
BOYCE, K.D. McCORMICK, J.C. HUNTER
Side-effect and pharmacokinetic profiles of the ?2C-adrenoceptor agonist
N-[3,4-Dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1,4-Benzoxazin-6-yl]-N-
methyl-N'-methylurea (Compound B). Will be Submitted to Pharmacology.
3. CORBOZ M.R, M.A. RIVELLI, H. SHAH, C.W. BOYCE, K.D. McCORMICK, R.W.
CHAPMAN, J.C. HUNTER
Role of ?2-adrenoceptors in electrical field stimulation-induced
contraction of pig nasal mucosa and pharmacologic characterization of a
novel ?2C-adrenoceptor agonist . Am. J. Rhinol. Allergy 26: 1-7, 2012.
4. CORBOZ M.R, M.A. RIVELLI, X. FERNANDEZ, S. GREENFEDER
The tachykinin NK3-receptor agonist [MePhe7]-neurokinin B potentiates
vagal stimulation-induced bronchoconstriction and produces
bronchoconstriction in the isolated perfused lung of non-sensitized and
ovalbumin-sensitized guinea pig. Exp. Lung Res. 38: 233-249, 2012.
5. CORBOZ, M.R., M.A. RIVELLI, K.D. MCCORMICK, Y. WAN, H. SHAH, S. UMLAND,
G. LIEBER, Y. JIA, R. McLEOD, C. MORGAN, G.B. VARTY, J. WU, K. FENG,
C.W. BOYCE, R.G. ASLANIAN, J. PALAMANDA, A. NOMEIR, W. KORFMACHER, J.C.
HUNTER, J.C. ANTHES, J.A. HEY
Pharmacological characterization of the novel ?2C-adrenoceptor agonist N-
[3,4-Dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1,4-Benzoxazin-6-yl]-N-ethyl-
N'-methylurea (Compound A). J. Pharmacol. Exp. Therap. 337: 256-266,
2011.
6. SANOU S.D., M. CORBOZ, G. BENCHETRIT, D. ANGLADE, GRIMBERT F.
Characteristiques de la filtration capillaire pulmonaire pendant une
augmentation du debit cardiaque associee a une vasodilatation. Int. J.
Biol. Chem. Sci. 4: 1278-1293, 2010.
7. TING P., J. LEE J., M. ALBANESE, J. WU, R. ASLANIAN, L. FAVREAU, C.
NARDO, W. KORFMACHER, R. WEST, S. WILLIAMS, J. ANTHES, M. RIVELLI, M.
CORBOZ, J. HEY.
The synthesis and structure-activity relationship of 4-benzimidazolyl-
piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.
Bioorganic & Medicinal Chemistry Letters 20: 5004-5008, 2010.
8. MINGO G.G., M.R. CORBOZ, B.G. SALISBURY, K.D. MCCORMICK, C.W. BOYCE, G.
MUKHOPADHVAY, R.L. MCLEOD
Alpha-2c adrenergic receptors contribute to basal nasal patency in the
anesthetized cat. Pharmacology 85: 259-263, 2010.
9. PALAMANDA J., H. MEI, R. MORRISON, R.L. MCLEOD, K. MCCORMICK, M. CORBOZ,
X. XU, W. KORFMACHER, L. BROSKE, A.A. NOMEIR
Pharmacokinetics of pseudoephedrine in rats, dogs, monkeys and its
pharmacokinetic-pharmacodynamic relationship in a feline model of nasal
congestion. Drug Metabolism Letters 4: 56-61, 2010.
10. CORBOZ M.R, M.A. RIVELLI, S.P. ECKEL, J.C. ANTHES
Bronchoconstrictor effects of the tachykinin NK3-receptor agonists
[MePhe7]-neurokinin B and senktide in the isolated guinea pig lung. Exp.
Lung Res. 36: 509-21, 2010.
MICHEL REMY CORBOZ
Page Five
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
11. PHILLIPS J.E., L. JI, M. RIVELLI, R.W. CHAPMAN, M.R. CORBOZ
Three-dimensional imaging and morphometric analysis of rodent paranasal
sinus cavities from X- ray computed tomography. Can. J. Vet. Med. 73: 205-
211, 2009.
12. CORBOZ M.R, J.E. PHILLIPS, L. de GARAVILLA
Introduction to pulmonary research group symposium upper airway disease:
Clinical and research perspectives. Pulm. Pharmacol. & Therap. 21: 431-
432, 2008.
13. CORBOZ M.R, M.A. RIVELLI, G.G. MINGO, R.L. McLEOD, L.M. VARTY, Y. JIA,
M. CARTWRIGHT, J.A. HEY
Mechanism of decongestant activity of ?2-adrenoceptor agonists. Pulm.
Pharmacol. & Therap. 21: 449-454, 2008.
14. CORBOZ M.R, X. FERNANDEZ, J.A. HEY
Increased blocking activity of combined tachykinin NK1- and NK2-receptor
antagonists on hyperventilation-induced bronchoconstriction in the
guinea pig. Pulm. Pharmacol. & Therap. 21: 67-72, 2008.
15. CORBOZ M.R, J.C. MUTTER, M.A. RIVELLI, G.G. MINGO, R.L. McLEOD, L.M.
VARTY, Y. JIA, M. CARTWRIGHT, J.A. HEY
?2-Adrenoceptor agonists as nasal decongestant. Pulm. Pharmacol. Ther.
20:149-56, 2007.
16. BERLIN M., P.C. TING, D.W. VACCARO, R. ASLANIAN, K.D. McCORMICK, J.F.
LEE, M.M. ALBANESE, M.W. MUTAHI, J.J. PIWINSKI, N.-Y. SHIH, L. DUGUMA,
D.M. SOLOMON, W. ZHOU, R. SHER, L. FAVREAU, M. BRYANT, W.A. KORFMACHER,
C. NARDO, R.E WEST, J.C. ANTHES, S.M. WILLIAMS, R.-L. WU, H.S. SHE, M.A.
RIVELLI, M.R. CORBOZ, J.A. HEY
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-
yl)methyl]piperidine series of histamine H3 receptor antagonists.
Bioorganic Medicinal Chemistry Letters. 16: 989-994, 2006.
17. VACCARO D.W., R. SHER, M. BERLIN, N.-Y. SHIH, R. ASLANIAN, J.H.
SCHWERDT, K.D. McCORMICK, J.J. PIWINSKI, R.E WEST, J.C. ANTHES, S.M.
WILLIAMS, R.-L. WU, H.S. SHE, M.A. RIVELLI, J.C. MUTTER, M.R. CORBOZ,
J.A. HEY, L. FAVREAU
Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-
yl)methyl]piperidine scaffold. Bioorganic Medicinal Chemistry Letters
16: 395-399, 2006.
18. CORBOZ M.R, M.A. RIVELLI, L.M. VARTY, J.C. MUTTER, M. CARTWRIGHT, C.A.
RIZZO, S.P. ECKEL, J.C. ANTHES, J.A. HEY
Pharmacological characterization of postjunctional ?2-adrenoceptors in
human nasal mucosa. Am. J. Rhinol. 19: 495-502, 2005.
19. CORBOZ M.R, L.M. VARTY, M.A. RIVELLI, J.C. MUTTER, G. MINGO, R.L.
McLEOD, R.W. EGAN, J.A. HEY
Effects of ?2-adrenoceptor agonists in nasal mucosa. Arch. Physiol.
Biochem. 111: 335-336, 2003.
20. CORBOZ M.R, L.M. VARTY, C.A. RIZZO, J.C. MUTTER, M.A. RIVELLI,, Y.
WAN, S.P. UMLAND, H. QIU, J. JAKWAY, K. McCORMICK, M.Y. BERLIN, J.A. HEY
Pharmacological characterization of ?2-adrenoceptor-mediated responses
in pig nasal mucosa. Auton. Autacoid Pharmacol. 23: 208-219, 2003.
21. CORBOZ M.R., X. FERNANDEZ, C.A. RIZZO, S. TOZZI, M.E. MONAHAN, J.A. HEY
Increased blocking activity of combined tachykinin NK1- and NK2-receptor
antagonists on tachykinergic bronchomotor responses in the guinea pig.
Auton. Autacoid Pharmacol. 23: 79-93, 2003.
MICHEL REMY CORBOZ
Page Six
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
22. RIZZO C.A., J. ANTHES, M.R. CORBOZ, R. CHAPMAN, N.-Y. SHIH, G.A.
REICHARD, K.J. NG, J.A. HEY
Development and potential utility of dual and triple NK receptor
antagonists. Curr. Topics Med. Chem. 3: 1410-1422, 2003.
23. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Tachykinin NK3 and NK1 receptor activation elicits secretion from
porcine airway submucosal glands. Br. J. Pharmacol. 138: 254-260, 2003.
24. ANTHES J.C., R.C. CHAPMAN, C. RICHARD, S. ECKEL, M. CORBOZ, J.A. HEY,
X. FERNANDEZ, S. GREENFEDER, R. McLEOD, S. SHERING, C. RIZZO, Y.
CRAWLEY, N.-Y. SHIH, J. PIWINSKI, G. REICHARD, P. TING, N. CARRUTHERS,
F.M. CUSS, M. BILLAH, W. KREUTNER, R.W. EGAN
SCH 206272: a potent, orally active tachykinin NK1, NK2, and NK3
receptor antagonist. Eur. J. Pharmacol. 450(2): 191-202, 2002.
25. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Effects of ion transport inhibitors on MCh-mediated secretion from
porcine airway submucosal glands. J. Appl. Physiol. 93: 873-881, 2002.
26. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Automated measurement of airway gland secretions by the Hillocks
technique. Computer Methods and Programs in Biomedicine 68: 215-222,
2002.
27. JIA Y., S.I. APONTE, C. WANG, M.A. RIVELLI, R. YANG, C. RIZZO, M.R.
CORBOZ, T. PRIESTLEY, J.A. HEY
Nociceptin inhibits capsaicin-induced tachykinin release in isolated
guinea pig lung and Ca2+ response in nodose ganglia cells. Br. J.
Pharmacol. 135: 764-770, 2002.
28. TROUT L., M.R CORBOZ, S.T. BALLARD
Mechanism of substance P-induced bicarbonate and liquid secretion across
porcine bronchial epithelium. Am. J. Physiol. (Lung Cell. Mol.
Physiol.) 181: L639-L645, 2001.
29. CORBOZ M.R, X. FERNANDEZ, R.W. EGAN, J.A. HEY
Inhibitory activity of nociceptin/orphanin FQ on capsaicin-induced
bronchoconstriction in the guinea-pig. Life Sciences 69(10): 1203-1211,
2001.
30. GREENFEDER S., S. SEHRING, N. McHUGH, M. CORBOZ, M. RIVELLI, J.C.
ANTHES, M. BILLAH, R.W. EGAN, R.W. CHAPMAN
Tryptase-induced airway microvascular leakage in guinea pigs. Eur. J.
Pharmacol. 419: 261-267, 2001.
31. RIZZO C.A., L.M. RUCK, M.R. CORBOZ, S.P. UMLAND, Y. WAN, H. SHAH, J.
JAKWAY, L. CHENG, K. McCORMICK, R.W. EGAN, J.A. HEY
Postjunctional ?2c-adrenoceptor contractility in human saphenous vein.
Eur. J. Pharmacol. 413: 263-269, 2001.
32. CORBOZ M.R., S. T. BALLARD, H. GAO, J.N. BENOIT, S.K INGLIS, A.E.
TAYLOR
Differential effects of furosemide on porcine bronchial arterial and
airway smooth muscle. J. Appl. Physiol. 89: 1360-1364, 2000.
33. CORBOZ M.R, M.A. RIVELLI, R.W. EGAN, D. TULSHIAN, J. MATASI, A.B.
FAWZI, L. BENBOW, A. SMITH-TORHAN, H. ZHANG, J.A. HEY
Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated
guinea pig lung. Eur. J. Pharmacol. 402: 171-179, 2000.
MICHEL REMY CORBOZ
Page Seven
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
34. MCLEOD R.L., G.G. MINGO, C. HERCZKU, M.R. CORBOZ, S. J. RAMOS, F.
DEGENNARO-CULVER, O. PEDERSEN, J.A. HEY
Changes in nasal resistance and nasal geometry using pressure and
acoustic rhinometry in a feline model of nasal congestion. Am. J.
Rhinol. 13: 375-383, 1999.
35. CORBOZ M.R, M.A. RIVELLI, S.J. RAMOS, C.A. RIZZO, J.A. HEY
Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary
arteries. Eur. J. Pharmacol. 350: R1-R3, 1998.
36. CORBOZ M.R, S.T. BALLARD
Intravital microscopy: airway circulation. In: Methods in Pulmonary
Research. Edited by S. Uhlig and A.E. Taylor. Published by Birkhauser
Publisher (Boston), USA, 93-107, 1998.
37. INGLIS S.K, M.R CORBOZ, S.T. BALLARD
Effect of anion secretion inhibitors on mucin content of airway
submucosal gland ducts. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol.
18): L762-L766, 1998.
38. ANGLADE D.J., M. CORBOZ, A. MENOUAR, J.C. PARKER, S. SANOU, S. BAYAT,
G. BENCHETRIT, F. GRIMBERT
Flow vs venous pressure effects on filtration coefficient in oleic acid-
injured lung. J. Appl. Physiol. 84: 1011-1023, 1998.
39. MENAOUAR A., D.J. ANGLADE, P. BAUSSAND, A. PELLOUX, M. CORBOZ, F.
GRIMBERT
Mechanism of chlorine gas-induced lung injury. Eur. Respir. J. 10: 1100-
1107, 1997.
40. CORBOZ M.R, S. T. BALLARD, S.K INGLIS, A.E. TAYLOR
Vasodilatory effect of furosemide on rat tracheal arterioles and
venules. Am J. Respir. Crit. Care Med. 156: 478-483, 1997.
41. INGLIS S.K, M.R CORBOZ, S. T. BALLARD, A.E. TAYLOR
Effect of anion transport inhibition on mucus secretion by airway
submucosal glands. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16):
L372-L377, 1997.
42. INGLIS S.K, M.R CORBOZ, S.T. BALLARD, A.E. TAYLOR
In situ visualization of bronchial submucosal glands and their secretory
response to acetylcholine. Am J. Physiol. 272 (Lung Cell. Mol. Physiol.
16): L203-L210, 1997.
43. CORBOZ M.R, S. T. BALLARD, S.K INGLIS, A.E. TAYLOR
Tracheal microvascular responses to inhibition of nitric oxide synthesis
in anesthetized rats. Am J. Respir. Crit. Care Med. 154: 1382-1386,
1996.
44. GRIMBERT F., A. MENAOUAR, D. ANGLADE, S, SANOU, M. CORBOZ
Filtration and capillary permeability. In: Clinical Microcirculation.
Edited by M. Vayssairat and P. Carpentier. Published by Masson (Paris),
15-24, 1996.
45. INGLIS S.K, M.R CORBOZ, S.T. BALLARD, A.E. TAYLOR
Regulation of ion transport across porcine distal bronchi. Am J.
Physio1. 270 (Lung Cell. Mol. Physiol. 14): L289-L297, 1996.
46. CORBOZ M.R, S. T. BALLARD, S.K INGLIS, A.E. TAYLOR
Tracheal microvascular responses to ?-adrenergic stimulation in
anesthetized rats. Am J. Respir. Crit. Care Med. 153: 1093-1597,1996.
47. CORBOZ M., S. SANOU, F. GRIMBERT
Capillary pressure estimates from arterial and venous occlusion in
intact dog lung. Eur. Respir. J. 8: 1122-1129,1995.
MICHEL REMY CORBOZ
Page Eight
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
48. BALLARD S.T., J.D. FOUNTAIN, S.K INGLIS, M.R CORBOZ, A.E. TAYLOR
Chloride secretion across distal airway epithelium: Relationship to
submucosal gland distribution. Am J. Physiol. 268 (Lung Cell. Mol.
Physiol. 12): L526-L531, 1995.
49. CORBOZ M.R, S.T. BALLARD, A.E. TAYLOR
Distribution of functional adrenergic receptor subtypes in the
microcirculation of rat trachea. Am J. Respir. Crit. Care Med. 151 (5):
1589-1596, 1995.
50. GRIMBERT F., M. CORBOZ, S. SANOU, D. MARTIN, G. BENCHETRIT
Lymph flow and protein content as an index of microvascular filtration.
In: Progress in Lymphology-xm. Edited by R. V Cluzan, A.P. Pecking, F.M.
Lokiec. Published by Excerpta Medica, Elsevier, The Netherlands, 153-
157, 1992.
51. CORBOZ M.
Etude experimentale des pressions d'occlusion arterielle et veineuse
dans la circulation pulmonaire. Doctoral dissertation in Biology,
University Joseph Fourier, Grenoble, France, 1992.
MICHEL REMY CORBOZ
Page Nine
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
Abstracts
1. CORBOZ M.R., S. FATHALLA.
The role of lung vasculature on postmortem bronchoconstriction in non-
sensitized and ovalbumin-sensitized guinea pigs. Am. J. Respir. Crit.
Care Med. 183: A2885, 2011.
2. CORBOZ M.R., S. FATHALLA, A. HOUSE, R.W. CHAPMAN, J.C. ANTHES.
Effect of arginase on muscarinic-induced contractility in isolated
bronchi and trachea of non-challenged and allergen-challenged guinea
pig. Am. J. Respir. Crit. Care Med. 183: A2583, 2011.
3. CORBOZ M.R., M.A. RIVELLI, G. Lieber, Y. Jia, R.L. McLeod, H. Shah, S.P.
Umland, C.W. Boyce, J. Wu, K.D. McCormick, J.A. Hey
Pharmacological characterization of the ?2C-adrenoceptor agonist
Compound A in binding, in vitro and in vivo assays. Am. J. Respir. Crit.
Care Med. 181: A4216, 2010.
4. CORBOZ M.R., M.A. RIVELLI, K.D. McCORMICK, J.E. PHILLIPS, J.C. ANTHES.
Role of ?-adrenoceptors in electrical field stimulation-induced
contraction of isolated pig nasal mucosa. Am. J. Respir. Crit. Care Med.
181: A4217, 2010
5. CORBOZ M.R., M.A. RIVELLI, J.E. PHILLIPS, R.W. CHAPMAN, J.C. ANTHES.
Role of nitric oxide and arginase on muscarinic-induced contractility in
isolated trachea of non-challenged and allergen-challenged Brown Norway
rat. Am. J. Respir. Crit. Care Med. 181: A2833, 2010
6. McLeod R.L., G.G Mingo, Y. Crawley, M.R. Corboz, Y. Jia, K.D. McCormick,
J.A. Hey
Characterization of the ?2c adrenergic agonist Compound A in
experimental animal models of nasal congestion. Am. J. Respir. Crit.
Care Med. 181: A4210, 2010
7. CORBOZ M.R., M.A. RIVELLI, S. SKEANS, K. McCORMICK, R. CHAPMAN, J.E.
PHILLIPS, J.C. ANTHES.
Vasodilatory and secretagogue roles of the prostaglandin D2 (PGD2)
receptor in nasal mucosa and airways of different species. Am. J.
Respir. Crit. Care Med. 179: A5699, 2009.
8. CORBOZ M.R., M.A. RIVELLI, A. DESAI-MERCHANT, M. ANAND, K.SMITH, J.E.
PHILLIPS, R. CHAPMAN, J.C. ANTHES
Effects of two days cigarette smoke exposure in isolated perfused rat
lung and pulmonary inflammation. Am. J. Respir. Crit. Care Med. 179:
A2027, 2009.
9. CORBOZ M.R., M.A. RIVELLI, G. MINGO, G. MUKHOPADHYAY, B. SALISBURY,R.L.
McLEOD, J.C. ANTHES
Binding, in vitro and in vivo decongestant activities of the standard
decongestant pseudoephedrine. Am. J. Respir. Crit. Care Med. 177: A625,
2008.
10. CORBOZ M.R., M.A. RIVELLI, J.C. ZIMMER, J.C. ANTHES
Pharmacological characterization of the ?-adrenoceptors in dog nasal
mucosa. Am. J. Respir. Crit. Care Med. 177: A626, 2008.
11. CORBOZ M.R., M.A. RIVELLI, G. MINGO, R.L. McLEOD
Effects of the selective ?1-adrenoceptor agonist phenylephrine in nasal
contractile bioassays and congestion model. Am. J. Respir. Crit. Care
Med. 175: A200, 2007.
MICHEL REMY CORBOZ
Page Ten
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
12. CORBOZ M.R., M.A. RIVELLI, D.Y. KONG
Effect of ascorbic acid on ?-adrenoceptor agonists-induced contractions
in pig nasal mucosa and human saphenous vein. Am. J. Respir. Crit. Care
Med. 175: A199, 2007.
13. PHILLIPS J.R., L. JI, M.R. CORBOZ
Volume quantification of mouse, rat, and guinea pig paranasal sinus
cavities by CT imaging and computer assisted three-dimensional
reconstruction. Am. J. Respir. Crit. Care Med. 175: A671, 2007.
14. CORBOZ M.R., M.A. RIVELLI, J.C. MUTTER, G. MINGO, R.L. McLEOD, J.A.
HEY
Nasal contractility and decongestant effects of ?2-adrenoceptor
agonists. Am. J. Respir. Crit. Care Med., 2006.
15. JIA Y., G. DIAZ, M. CORBOZ, J.A. HEY
?-Adrenoceptor-mediated contractions of capacitance and resistance
vessels in porcine nasal mucosa explants. Am. J. Respir. Crit. Care
Med., 2006.
16. CORBOZ M.R., J.C. MUTTER, M.A. RIVELLI, J.A. HEY
Effect of the tachykinin NK1-receptor agonist [Met-OMe11]Substance P and
the calcitonin gene-related peptide-receptor agonist CGRP in dog, pig,
monkey and human nasal mucosa. Am. J. Respir. Crit. Care Med. A340,
2005.
17. CORBOZ M.R., V. JOGUPARTHI, J.C. MUTTER, P. WANG, J.A. HEY
Effect of neuropeptide Y and calcitonin-gene related peptide in pig
nasal mucosa. FASEB J. 18: A248, 2004.
18. CORBOZ M.R., J.C. MUTTER, C.A. RIZZO, J.A. HEY
?1- And ?2-adrenoceptor agonist responses in monkey nasal mucosa. Am. J.
Respir. Crit. Care Med. 169: A821, 2004.
19. CORBOZ M.R., M.A. RIVELLI, X. FERNANDEZ, J.A. HEY
The tachykinin NK3 agonist (N-Me-Phe7) neurokinin B potentiates vagal
stimulation-induced bronchoconstriction in the isolated guinea pig lung.
Am. J. Respir. Crit. Care Med. 167: A149, 2003.
20. CORBOZ M.R., J.C. MUTTER, L.M. RUCK, G. MINGO, R.L. McLEOD, S.P.
UMLAND, Y. WAN, J. JAKWAY, H. QIU, K.D. McCORMICK, J.A. HEY
Binding, in vitro and in vivo decongestant activities of ?-adrenergic
receptor agonists ST-91 and SK&F 35886. Am. J. Respir. Crit. Care Med.
167: A218, 2003.
21. CORBOZ M.R., M.A. RIVELLI, C.A. RIZZO, J.A. HEY
?1- and ?2-Adrenoceptors mediate vasoconstriction in human nasal mucosa.
Am. J. Respir. Crit. Care Med. 167: A425, 2003.
22. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Effects of ion transport inhibitors on methacholine mediated secretion
from porcine airway submucosal glands. Am. J. Respir. Crit. Care Med.
167: A424, 2003.
MICHEL REMY CORBOZ
Page Eleven
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
23. VARTY, L.M., J.E. PHILLIPS, M.R. CORBOZ, Y. JIA, J.A. HEY
Differential ?2- and ?1-adrenoceptor real-time vasomotor contractions in
isolated porcine nasal mucosa. Am. J. Respir. Crit. Care Med. 167: A425,
2003.
24. CORBOZ M.R., C.A. RIZZO, X. FERNANDEZ, S. TOZZI, M.E. MONAHAN, J.A. HEY
Increased activity of combined NK1/NK2 blockade on tachykinin-induced
constriction in isolated bronchus, isolated lung and in vivo guinea
pigs. Am. J. Respir. Crit. Care Med. 165: B40, 2002.
25. CORBOZ M.R., J.C. MUTTER, M.A. RIVELLI, L.M. RUCK, C.A. RIZZO, G.
MINGO, R.L. McLEOD, Y. WAN, S.P. UMLAND, M.Y. BERLIN, J.A. HEY
Pharmacological characterization of ?-adrenergic receptor agonists
oxymetazoline and PGE-6201204 in binding, in vitro bioassays and in an
in vivo decongestant model. Am. J. Respir. Crit. Care Med. 165: A326,
2002.
26. CORBOZ M.R., M.A. RIVELLI, S. GREENFEDER, J.A. HEY
Tachykinin NK-3 receptor agonist produces bronchoconstriction in the
isolated guinea-pig lung. Am. J. Respir. Crit. Care Med. 165: A721,
2002.
27. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Effects of neurokinin agonists and antagonists on submucosal gland
secretion from porcine airways. Am. J. Respir. Crit. Care Med. 165:
A722, 2002.
28. JIA Y., X. WANG, M.A. RIVELLI, M.R. CORBOZ, R.L. McLEOD, T. PRIESTLEY,
R.W. EGAN, J.A. HEY
Nociceptin/Orphanin FQ inhibits capsaicin-induced guinea pig airway
contraction through the activation of an inward-rectifier potassium
channel. Am. J. Respir. Crit. Care Med. 165: A719, 2002.
29. CORBOZ M.R., M.A. RIVELLI, C.A. RIZZO, J.A. HEY
Chloride channels mediate tachykinin NK-1 receptor agonist-induced
relaxation in human pulmonary arteries. FASEB J. 16: A71, 2002.
30. MUTTER J., M. RIVELLI, L.M. RUCK, C.A. RIZZO, J.A. HEY, M.R. CORBOZ.
Pharmacological characterization of ?1- and ?2- adrenoceptor agonist
responses in canine turbinate mucosa. FASEB J. 16: A127, 2002.
31. CORBOZ M.R., X. FERNANDEZ, R.W. EGAN, J.A. HEY
Nociceptin inhibits capsaicin-induced bronchoconstriction in the guinea-
pig. Am. J. Respir. Crit. Care Med. 163: A626, 2001.
32. PHILLIPS J.E., J.A. HEY, M.R. CORBOZ
Amiloride increases methacholine-induced tracheal submucosal gland fluid
flux in porcine tracheal epithelia. Am. J. Respir. Crit. Care Med. 163:
A406, 2001.
33. JIA Y., S.I. APONTE, M.A. RIVELLI, M.R. CORBOZ, J.H. CRONA, Z.X. DONG,
T. PRIESTLEY, J.A. HEY
Nociceptin inhibits capsaicin-induced tachykinin release in isolated
guinea pig lungs. Am. J. Respir. Crit. Care Med. 163: A826, 2001.
34. CORBOZ M.R., M.A. RIVELLI, C.A. RIZZO, J.A. HEY
Tachykinin NK-1 receptor agonist-induced relaxation in human pulmonary
arteries is not mediated by potassium channels. FASEB, 2001
35. RUCK L.M., C.A. RIZZO, M.R. CORBOZ, R. YANG, M. RIVELLI, J. MUTTER,
J.A. HEY
Pharmacological characterization of the ?2-adrenergic agonist responses
in porcine turbinate mucosa. FASEB, 2001
MICHEL REMY CORBOZ
Page Twelve
Home: 732-***-**** onjmmc@r.postjobfree.com Cell: 732-***-****
36. CORBOZ M.R., S.I. APONTE, M.A. RIVELLI, C.A. RIZZO, J.A. HEY
Differential role of tachykinin NK-1 and NK-2 receptors on vascular tone
in human pulmonary arteries. Am. J. Respir. Crit. Care Med. 161: A410,
2000.
37. RUCK L.M., C.A. RIZZO, J.A. HEY, R.W. EGAN, S.P. UMLAND, Y. WAN, H.
SHAH, J.JAKWAY, L. CHENG, J. SHORTALL, M.R. CORBOZ
Pharmacological characterization of the ?-2c adrenergic receptor in
human saphenous vein. FASEB J. 14: A1315, 2000.
38. RIVELLI M.A., M.R. CORBOZ, X. FERNANDEZ, J.A. HEY
Increased activity of combined NK1/NK2 blockade on tachykinin-induced
bronchoconstriction in isolated lung and in vivo in the guinea pigs. Am.
J. Respir. Crit. Care Med. 159: A281, 1999.
39. FERNANDEZ X., M.R. CORBOZ, J.A. HEY
Combination of NK1 and NK2 antagonists produces an increased blockade of
hyperventilation-induced bronchoconstriction in guinea pigs. Am. J.
Respir. Crit. Care Med. 159: A281, 1999.
40. CORBOZ M.R., S.I. RAMOS, M.A. RIVELLI, C.A. RIZZO, J.A. HEY
Mechanism of tachykinin NK-1 receptor agonist-induced relaxation in
human pulmonary arteries. Am. J. Respir. Crit. Care Med. 159: A572,
1999.
41. CORBOZ M.R., S.I. RAMOS, M.A. RIVELLI, C.A. RIZZO, J.A. HEY
Characterization of neurokinin NK-l